A well-designed cell and gene therapy supply chain is critical to patient care. Managing the cell therapy supply chain is a mission-critical industry skill. Yet, no matter how well designed your supply chain is, human-based therapies are subject to variability at each stage of delivery. At Be The Match BioTherapies®, we make sure our team…
It’s no secret that cell and gene therapies are advancing at a rapid pace. As with any new innovations, unforeseen challenges are sure to accompany. One of the challenges generating buzz lately, is the need to define standards in the industry, specifically in the areas of apheresis collection and manufacturing. So, we’re going straight to…
On May 30, Be The Match BioTherapies® brought together key cell and gene therapy professionals to discuss two big challenges that are impacting the entire industry: system capacity and the need for standardization. The main goal of this event? Brainstorm, collaborate and strategize ways to develop standards that will help to ease the current burden…
Cell therapies represent some of the most logistically complex treatments ever created, with quality and viability dependent on seamless coordination across multiple steps. With the first CAR-T therapies now approved, and more companies entering this new terrain, managing the cell therapy supply chain has become a mission-critical industry skill. We asked two supply chain experts…